Picture of Caplin Point Laboratories logo

CAPLIPOINT — Caplin Point Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For Its ANDA Acetaminophen Injection

Dec 8 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS:

CAPLIN POINT LABORATORIES LTD - UNIT RECEIVES FINAL USFDA APPROVAL FOR ITS ANDA ACETAMINOPHEN INJECTION

Source text: ID:nNSE19xKFl

Further company coverage: CAPL.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Caplin Point Laboratories

See all news